Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
96.9
%
| 27 | 96.5 % | 31 | 96.9 % | +13.61% |
Insecticide
3.1
%
| 1 | 3.5 % | 1 | 3.1 % | -0.21% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
95.9
%
| 27 | 96.7 % | 30 | 95.9 % | +12.16% |
Middle East
3.3
%
| 1 | 2.4 % | 1 | 3.3 % | +53.27% |
United States
0.8
%
| 0 | 0.8 % | 0 | 0.8 % | +7.49% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
René C. Goehrum
CEO | Chief Executive Officer | 64 | 31/12/95 |
Robert March
DFI | Director of Finance/CFO | - | 09/09/18 |
Navid Ashrafi
CTO | Chief Tech/Sci/R&D Officer | - | 30/04/14 |
Neelu Atwal
HRO | Human Resources Officer | - | 31/12/18 |
Corporate Officer/Principal | - | 31/07/15 | |
Kevin Wilson
PRN | Corporate Officer/Principal | - | 29/02/12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sara Elford
BRD | Director/Board Member | 53 | 07/01/18 |
René C. Goehrum
CEO | Chief Executive Officer | 64 | 31/12/95 |
Peter Lockhard
BRD | Director/Board Member | 60 | 31/05/02 |
Larry Andrews
BRD | Director/Board Member | 71 | 07/01/18 |
Joseph Arcuri
BRD | Director/Board Member | 58 | 28/05/18 |
Stephen Wilton
BRD | Director/Board Member | 63 | 15/01/14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,965,962 | 7,254,734 ( 60.63 %) | 175,753 ( 1.469 %) | 60.63 % |
Company contact information
![address BioSyent Inc.(BIOYF)](https://cdn.zonebourse.com/static/address/183845.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |